Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 12/20 | 0.54 |
| ▸ | MMP1 | P03956 | 11/20 | 0.54 |
| ▸ | MMP3 | P08254 | 10/20 | 0.54 |
| ▸ | MMP8 | P22894 | 2/20 | 0.52 |
| ▸ | GNPAT | O15228 | 1/20 | 0.51 |
| ▸ | MMP7 | P09237 | 3/20 | 0.51 |
| ▸ | MMP9 | P14780 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22388988 | 0.93 | GNPAT (0.53) | MMP2GNPAT | |
| SCHEMBL25062089 | 0.90 | MMP2 (0.53) | MMP2MMP1MMP3MMP7 | |
| SCHEMBL20159738 | 0.89 | MMP2 (0.57) | MMP2MMP1MMP3MMP8GNPAT | |
| SCHEMBL22045372 | 0.89 | GNPAT (0.52) | MMP2GNPAT | |
| SCHEMBL13344145 | 0.88 | GHSR (0.57) | MMP2MMP1MMP3MMP8 | |
| SCHEMBL24766217 | 0.88 | GNPAT (0.60) | MMP2GNPAT | |
| SCHEMBL20356789 | 0.88 | GHSR (0.57) | MMP2MMP1MMP3MMP8 | |
| SCHEMBL10525421 | 0.88 | GNPAT (0.59) | GNPAT | |
| SCHEMBL23128421 | 0.87 | GNPAT (0.52) | MMP2MMP1MMP3GNPATMMP9 | |
| SCHEMBL21549718 | 0.87 | GHSR (0.55) | GNPAT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230115871-A1 | A CONJUGATE OF A CYTOTOXIC AGENT TO A CELL BINDING MOLECULE WITH BRANCHED LINKERS | HANGZHOU DAC BIOTECH CO., LTD (CN) | 2023-04-13 | — | — | US | disclosed |
| US-20210308277-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2021-10-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230115871-A1 | A CONJUGATE OF A CYTOTOXIC AGENT TO A CELL BINDING MOLECULE WITH BRANCHED LINKERS | CD2BP2, EPCAM, CD74 | MMP2 3043/4885MMP1 3931/4885MMP3 3124/4885 |
| US-20210308277-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | CD2BP2, DCLRE1A, EPCAM | MMP2 1828/4885MMP1 2096/4885MMP3 1250/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.